BDPT BIOADAPTIVES, INC. revenue, earnings and financials

For the quarter ended June 30, 2026, BIOADAPTIVES, INC. reported revenue of $4.99K (up 55.0% from a year earlier), net income of $150K and diluted EPS of $0.00; over the last four quarters revenue was $25.6K and net income −$1.16M; for the fiscal year ended December 2025 revenue was $18.3K, up 44.3% on the year before.

BDPT annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $18.3K, gross profit $12.5K, operating income −$1.04M, net income −$1.56M (margin -8523.4%), EPS −$0.15
• Fiscal year ended Dec 2024: revenue $12.7K, gross profit $4.03K, operating income −$602K, net income −$899K (margin -7097.3%), EPS −$0.11
• Fiscal year ended Dec 2023: revenue $28.6K, gross profit $10.8K, operating income −$229K, net income −$712K (margin -2494.2%), EPS n/a
• Fiscal year ended Dec 2022: revenue $17.2K, gross profit $7.13K, operating income −$422K, net income −$896K (margin -5214.1%), EPS n/a
• Fiscal year ended Dec 2021: revenue $19.8K, gross profit $10.1K, operating income n/a, net income −$1.05M (margin -5309.2%), EPS n/a

BDPT quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $4.99K (up 55.0% year over year), net income $150K, EPS $0.00
• Quarter ended Mar 31, 2026: revenue $5.51K, net income −$111K, EPS −$0.01
• Quarter ended Dec 31, 2025 (from the annual report): revenue $10.4K, net income −$823K, EPS −$0.07
• Quarter ended Sep 30, 2025: revenue $4.63K, net income −$380K, EPS −$0.04
• Quarter ended Jun 30, 2025: revenue $3.22K (up 376.9% year over year), net income −$158K, EPS −$0.02
• Quarter ended Mar 31, 2025: revenue $0 (down 100.0% year over year), net income −$197K, EPS −$0.02
• Quarter ended Dec 31, 2024 (from the annual report): revenue $0 (down 100.0% year over year), net income −$372K, EPS −$0.13
• Quarter ended Sep 30, 2024: revenue $0 (down 100.0% year over year), net income −$37.6K, EPS $0.00
• Quarter ended Jun 30, 2024: revenue $675 (down 71.1% year over year), net income −$183K, EPS $0.06
• Quarter ended Mar 31, 2024: revenue $12.0K (up 255.3% year over year), net income −$307K, EPS −$0.04
• Quarter ended Dec 31, 2023 (from the annual report): revenue $7.20K (up 80.7% year over year), net income −$268K, EPS n/a
• Quarter ended Sep 30, 2023: revenue $15.6K (up 369.0% year over year), net income −$13.1K, EPS n/a
• Quarter ended Jun 30, 2023: revenue $2.34K (down 45.9% year over year), net income −$144K, EPS n/a
• Quarter ended Mar 31, 2023: revenue $3.38K (down 39.0% year over year), net income −$287K, EPS n/a
• Quarter ended Dec 31, 2022 (from the annual report): revenue $3.98K (up 3.5% year over year), net income −$28.3K, EPS n/a
• Quarter ended Sep 30, 2022: revenue $3.34K (down 37.5% year over year), net income −$276K, EPS n/a
• Quarter ended Jun 30, 2022: revenue $4.32K (down 28.7% year over year), net income −$224K, EPS n/a
• Quarter ended Mar 31, 2022: revenue $5.53K (up 22.5% year over year), net income −$367K, EPS n/a
• Quarter ended Dec 31, 2021 (from the annual report): revenue $3.85K, net income −$214K, EPS n/a
• Quarter ended Sep 30, 2021: revenue $5.34K, net income −$34.5K, EPS $0.00

BDPT cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$516K, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$250K, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$224K, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$227K, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$159K, share buybacks n/a

BDPT balance sheet

• Jun 30, 2026: cash n/a, total assets $78.8K, total liabilities $1.84M, shareholders' equity −$1.77M
• Mar 31, 2026: cash n/a, total assets $136K, total liabilities $2.27M, shareholders' equity −$2.14M
• Dec 31, 2025: cash $215K, total assets $226K, total liabilities $2.36M, shareholders' equity −$2.13M
• Sep 30, 2025: cash n/a, total assets $124K, total liabilities $1.59M, shareholders' equity −$1.47M
• Jun 30, 2025: cash n/a, total assets $273K, total liabilities $1.41M, shareholders' equity −$1.14M
• Mar 31, 2025: cash n/a, total assets $110K, total liabilities $1.68M, shareholders' equity −$1.57M
• Dec 31, 2024: cash $262K, total assets $262K, total liabilities $1.73M, shareholders' equity −$1.46M
• Sep 30, 2024: cash n/a, total assets $46.4K, total liabilities $1.85M, shareholders' equity −$1.81M

What is BDPT's revenue?

BIOADAPTIVES, INC. reported $25.6K of revenue over its last four quarters, through June 30, 2026.

Is BDPT profitable?

No. BIOADAPTIVES, INC. lost $1.16M over the last four quarters.

What is BDPT's EPS?

Diluted earnings per share over the last four quarters were −$0.12; $0.00 in the latest quarter.

BDPT ownership and insider trades · All stocks